Co-Authors
This is a "connection" page, showing publications co-authored by Michael Ujiki and Mark Talamonti.
Connection Strength
1.918
-
Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol. 2007 Aug; 34(4):311-20.
Score: 0.300
-
Surgical management of pancreatic cancer. Semin Radiat Oncol. 2005 Oct; 15(4):218-25.
Score: 0.264
-
Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). Ann Surg. 2018 04; 267(4):716-720.
Score: 0.157
-
Rectus abdominis atrophy after ventral abdominal incisions: midline versus chevron. Hernia. 2017 08; 21(4):619-622.
Score: 0.147
-
Educating surgeons may allow for reduced intraoperative costs for inguinal herniorrhaphy. J Am Coll Surg. 2015 Jun; 220(6):1107-12.
Score: 0.127
-
Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Surg Endosc. 2015 Dec; 29(12):3528-34.
Score: 0.127
-
Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients. Surg Endosc. 2014 Oct; 28(10):2803-7.
Score: 0.120
-
Laparoscopic ischemic conditioning of the stomach prior to esophagectomy. Dis Esophagus. 2013 Jul; 26(5):479-86.
Score: 0.106
-
Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg. 2011 Mar; 201(3):295-9; discussion 299-300.
Score: 0.096
-
Laparoscopic distal pancreatectomy using radiofrequency energy. Am J Surg. 2010 Mar; 199(3):401-4; discussion 404.
Score: 0.090
-
A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery. 2009 Oct; 146(4):635-43; discussion 643-5.
Score: 0.087
-
Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
Score: 0.076
-
Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006 Dec 29; 5:76.
Score: 0.072
-
A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.
Score: 0.067
-
Educating surgeons on intraoperative disposable supply costs during laparoscopic cholecystectomy: a regional health system's experience. Am J Surg. 2015 Mar; 209(3):488-92.
Score: 0.031
-
Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 Apr; 138(2):163-9.
Score: 0.018
-
Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer. 2005 Aug 05; 4:27.
Score: 0.016
-
Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. Biochem Biophys Res Commun. 2004 Oct 29; 323(4):1241-5.
Score: 0.016